| Width | 225px |
|---|---|
| Routes of administration | Oral[1] |
| Class | Psychoactive drug; Stimulant; Antidepressant |
| Atc prefix | None |
| Duration of action | 20–30 hours[1] |
| Cas number | 207740-21-4 |
| Pubchem | 21796713 |
| Chemspiderid | 10546842 |
| Unii | O5LSQ8027D |
| Chembl | 332505 |
| Synonyms | 2C-G-NPH; 2C-NPH; 1,4-Dimethoxynaphthyl-2-ethylamine |
| Iupac name | 2-(1,4-dimethoxynaphthalen-2-yl)ethanamine |
| C | 14 |
| H | 17 |
| N | 1 |
| O | 2 |
| Smiles | COC1=CC(=C(C2=CC=CC=C21)OC)CCN |
| Stdinchi | 1S/C14H17NO2/c1-16-13-9-10(7-8-15)14(17-2)12-6-4-3-5-11(12)13/h3-6,9H,7-8,15H2,1-2H3 |
| Stdinchikey | VKWQEEWEGKDTDE-UHFFFAOYSA-N |
2C-G-N, or 2C-G-NPH, also known as 1,4-dimethoxynaphthyl-2-ethylamine, is a psychoactive drug of the phenethylamine, 2C, and naphthylethylamine families.[1] It is the derivative of 2C-G in which the 3,4-dimethyl groups have been extended and connected to form a second benzene ring and hence has a 2-naphthalene ring system.[1]
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-N's dose as 20 to 40 mg orally and its duration as 20 to 30 hours.[1][2][3] The effects of the drug were reported to include some amphetamine-like stimulation, some possible antidepressant-like effects, "not much psychedelic" but "something really going on anyway", faint uneasiness, and "not as friendly" of effects as other 2C-G compounds.[1] Its activity was described as "on the wane" compared to other 2C-G drugs and as lasting "too long".[1]
The chemical synthesis of 2C-G-N has been described.[1]
The drug was first described in the literature by Shulgin in PiHKAL in 1991.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[4]
See also
- 2C (psychedelics)
- Substituted naphthylethylamine
- 2C-G (2C-G-0)
- 2C-G-3 and 2C-G-5
- Ganesha and G-N
References
- ^ https://www.erowid.org/library/books_online/pihkal/pihkal031.shtml
- ^ Jacob P, Shulgin AT (1994). "Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs". Hallucinogens: An Update. Vol. 146. National Institute on Drug Abuse Research Monograph Series. National Institute on Drug Abuse. pp. 74–91. PMID 8742795. Archived 13 July 2025 at the Wayback Machine.
- ^ Shulgin AT (2003). "Basic Pharmacology and Effects". Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived 13 July 2025 at the Wayback Machine.
- ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.